Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis

Clinical trial NCT01078454 · COMPLETED

Trial details

NCT number: NCT01078454
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Light Chain Deposition Disease Primary Systemic Amyloidosis

Start date: 2010-11-01
Primary completion: 2012-11-12
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.